These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 16143696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C, van Veldhuisen DJ, van de Ven LL, Follath F, Goulder M, Willenheimer R, CIBIS-III investigators.
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [Abstract] [Full Text] [Related]

  • 3. Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
    Krum H, van Veldhuisen DJ, Funck-Brentano C, Vanoli E, Silke B, Erdmann E, Follath F, Ponikowski P, Goulder M, Meyer W, Lechat P, Willenheimer R, behalf of the CIBIS III Investigators.
    Cardiovasc Ther; 2011 Apr; 29(2):89-98. PubMed ID: 20528880
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
    van de Ven LL, van Veldhuisen DJ, Goulder M, Zilahi Z, Meyer WR, Willenheimer R.
    Int J Cardiol; 2010 Sep 24; 144(1):59-63. PubMed ID: 19481278
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M, Maack C, Wehrlen-Grandjean M, Erdmann E.
    Z Kardiol; 2003 Aug 24; 92(8):668-76. PubMed ID: 12955414
    [Abstract] [Full Text] [Related]

  • 8. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G, Gouya G, Hügel H, Frick M, Ulmer H, Pachinger O.
    Wien Klin Wochenschr; 2002 Oct 31; 114(19-20):833-9. PubMed ID: 12503474
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H, Demets D, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J, MERIT-HF Study Group.
    Am Heart J; 2001 Sep 31; 142(3):502-11. PubMed ID: 11526365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P, Roudaut R, Herrero G, Dallocchio M.
    J Cardiovasc Pharmacol; 1990 Sep 31; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [Abstract] [Full Text] [Related]

  • 16. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009 Sep 31; 20(1):78. PubMed ID: 19382368
    [No Abstract] [Full Text] [Related]

  • 17. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S, Dayi SU, Akbulut T, Dağ O, Köse H, Satiroğlu O, Sayar N, Bilsel T, Aksoy S, Yeşilçimen K.
    Anadolu Kardiyol Derg; 2003 Dec 31; 3(4):313-8. PubMed ID: 14675880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.